ETG Warszawa - PPDS

Warsaw, Masovian Voivodeship 02-677

1 studies enrolling now · 4 studies all time

What they study most

Plaque Psoriasis, Type II Diabetes Mellitus

Studies at this site

• A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus — Recruiting now
• A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
• A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis — Completed
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed